DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) will announce its earnings results before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.42 per share for the quarter. DENTSPLY SIRONA has set its FY 2024 guidance at 2.000-2.100 EPS and its FY24 guidance at $2.00-$2.10 EPS.Investors interested in registering for the company’s conference call can do so using this link.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last posted its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $972.61 million. During the same period last year, the company earned $0.46 EPS. DENTSPLY SIRONA’s revenue for the quarter was up 3.0% compared to the same quarter last year. On average, analysts expect DENTSPLY SIRONA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
DENTSPLY SIRONA Stock Performance
NASDAQ:XRAY opened at $30.92 on Thursday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38. DENTSPLY SIRONA has a fifty-two week low of $26.27 and a fifty-two week high of $43.24. The firm has a market cap of $6.41 billion, a PE ratio of -49.87, a price-to-earnings-growth ratio of 1.23 and a beta of 0.98. The business has a 50 day moving average price of $32.70 and a 200-day moving average price of $32.81.
DENTSPLY SIRONA Increases Dividend
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the stock. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. Barrington Research reissued an “outperform” rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Piper Sandler boosted their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Friday, January 12th. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $39.50.
Read Our Latest Research Report on XRAY
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories
- Five stocks we like better than DENTSPLY SIRONA
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- High-Yield Texas Instruments Could Hit New Highs Soon
- Most active stocks: Dollar volume vs share volume
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Roth IRA Calculator: Calculate Your Potential Returns
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.